Identification of a Nanobody Specific to Human Pulmonary Surfactant Protein A

Xian He,Shan-Mei Wang,Zhao Fang Yin,Meng-Meng Zhao,Nan Li,Feng Yu,Liu-Sheng Wang,Yang Hu,Yu-Kui Du,Shan-Shan Du,Yan Li,Ya-Ru Wei,Shan-Shan Chen,Jian-Hua He,Dong Weng,Hui-Ping Li

DOI: https://doi.org/10.1038/s41598-017-01456-2

IF: 4.6

2017-01-01

Scientific Reports

Abstract:Nanobody (Nb) is a promising vector for targeted drug delivery. This study aims to identify an Nb that can specifically target the lung by binding human pulmonary surfactant protein A (SP-A). Human lung frozen tissue sections were used for 3 rounds of biospanning of our previously constructed Nb library for rat SP-A to establish a sub-library of Nb, which specifically bound human lung tissues. Phage-ELISA was performed to screen the sub-library to identify Nb4, which specifically bound human SP-A. The binding affinity Kd of Nb4 to recombinant human SP-A was 7.48 × 10 −7 M. Nb4 (19 kDa) was stable at 30 °C–37 °C and pH 7.0–7.6 and specifically bound the SP-A in human lung tissue homogenates, human lung A549 cells, and human lung tissues, whereas didn’t react with human liver L-02 cells, kidney 293T cells, and human tissues from organs other than the lung. Nb4 accumulated in the lung of nude mice 5 minutes after a tail vein injection of Nb4 and was excreted 3 hours. Short-term exposure (one month) to Nb4 didn’t cause apparent liver and kidney toxicity in rats, whereas 3-month exposure resulted in mild liver and kidney injuries. Nb4 may be a promising vector to specifically deliver drugs to the lung.